Suppr超能文献

乙酰半胱氨酸联合粉防己碱片治疗矽肺患者的临床疗效及其对运动耐力和肺功能的影响

Clinical efficacy of acetylcysteine combined with tetrandrine tablets on patients with silicosis and its effect on exercise tolerance and pulmonary function.

作者信息

Guo Xiuzhi, Qi Jing, Li Huanxiang, Xing Zhaofeng

机构信息

Department II of Occupational Disease, Branch of Tai'an City Central Hospital, Tai'an, Shandong 271000, P.R. China.

Department of Public Health, Branch of Tai'an City Central Hospital, Tai'an, Shandong 271000, P.R. China.

出版信息

Exp Ther Med. 2020 Aug;20(2):1285-1290. doi: 10.3892/etm.2020.8858. Epub 2020 Jun 10.

Abstract

Clinical efficacy of acetylcysteine combined with tetrandrine tablets in the treatment of silicosis was investigated to observe the exercise tolerance and pulmonary function of the patients. The clinical data of 248 cases of silicosis patients treated in Branch of Tai'an City Central Hospital were retrospectively analyzed in this study, including 116 cases with conventional therapy (control group), and 132 cases treated with acetylcysteine and tetrandrine tablets on the basis of conventional therapy (observation group). The chest tightness, chest pain, cough and sputum production were evaluated by the St. George Respiratory questionnaire (SGRQ); and side effects after treatment were recorded. Exercise tolerance was measured by 6-min walk test (6MWT) and pulmonary function was measured by pulmonary function instrument. The symptoms of chest tightness, chest pain, cough and sputum production in the observation group and the control group after 8 months of treatment were significantly lower than those before treatment (P<0.05), and that in the observation group after treatment was significantly higher than that in the control group (P<0.05). The incidence of side effects of the drug in the observation group was significantly lower than that in the control group (P<0.05). The 6MWT, forced vital capacity (FVC) and forced expiratory volume in 1 sec (FEV1) in the observation group and the control group after treatment were significantly higher than those before treatment (P<0.001); the 6MWT in the observation group after treatment was significantly higher than that in the control group (P<0.001). In conclusion, acetylcysteine combined with tetrandrine tablets on the basis of conventional therapy in treatment of silicosis is more effective than conventional therapy alone, which can also improve exercise tolerance, pulmonary function and clinical symptoms such as chest tightness, chest pain, cough, sputum production of silicosis patients, and is helpful for clinical application.

摘要

研究乙酰半胱氨酸联合粉防己碱片治疗矽肺的临床疗效,观察患者的运动耐力和肺功能。本研究回顾性分析了泰安市中心医院分院收治的248例矽肺患者的临床资料,其中116例采用常规治疗(对照组),132例在常规治疗基础上加用乙酰半胱氨酸和粉防己碱片治疗(观察组)。采用圣乔治呼吸问卷(SGRQ)评估胸闷、胸痛、咳嗽咳痰情况;记录治疗后的不良反应。通过6分钟步行试验(6MWT)测量运动耐力,用肺功能仪测量肺功能。治疗8个月后,观察组和对照组的胸闷、胸痛、咳嗽咳痰症状均较治疗前明显减轻(P<0.05),且观察组治疗后症状改善程度明显高于对照组(P<0.05)。观察组药物不良反应发生率明显低于对照组(P<0.05)。治疗后,观察组和对照组的6MWT、用力肺活量(FVC)和第1秒用力呼气容积(FEV1)均较治疗前明显升高(P<0.001);观察组治疗后的6MWT明显高于对照组(P<0.001)。综上所述,在常规治疗基础上加用乙酰半胱氨酸联合粉防己碱片治疗矽肺比单纯常规治疗更有效,还可提高矽肺患者的运动耐力、肺功能及胸闷、胸痛、咳嗽、咳痰等临床症状,有助于临床应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/170c/7388567/d3383ec69ae9/etm-20-02-1285-g00.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验